Cargando…
COVID-19 does not influence functional status after ARDS therapy
RATIONALE: Health-related quality of life after surviving acute respiratory distress syndrome has come into focus in recent years, especially during the coronavirus disease 2019 pandemic. OBJECTIVES: A total of 144 patients with acute respiratory distress syndrome caused by COVID-19 or of other orig...
Autores principales: | Bernard, Alice, Serna-Higuita, Lina Maria, Martus, Peter, Mirakaj, Valbona, Koeppen, Michael, Zarbock, Alexander, Marx, Gernot, Putensen, Christian, Rosenberger, Peter, Haeberle, Helene Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899507/ https://www.ncbi.nlm.nih.gov/pubmed/36740717 http://dx.doi.org/10.1186/s13054-023-04330-y |
Ejemplares similares
-
Early vvECMO implantation may be associated with lower mortality in ARDS
por: Rosenberger, Peter, et al.
Publicado: (2023) -
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
por: Haeberle, Helene A., et al.
Publicado: (2023) -
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
por: Haeberle, Helene, et al.
Publicado: (2020) -
Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021) -
Neuronal guidance proteins in cardiovascular inflammation
por: Keller, Marius, et al.
Publicado: (2021)